News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Non-Dopaminergic Drug Preladenant Reduces Motor Fluctuations in Patients with Parkinson's Disease, University of South Florida Study


2/11/2011 7:13:46 AM

Physorg.com -- Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson's disease receiving standard dopamine therapy, an international study led by the University of South Florida found. Results of the double-blind, randomized clinical trial are reported online today in the journal Lancet Neurology.

Read at Physorg.com
Read at News Release
Read at E Science News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES